Proconvertin (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Proconvertin" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

9doi.org

2^nd place

8^th place

9nih.gov

4^th place

11^th place

2web.archive.org

1^st place

2worldcat.org

5^th place

22^nd place

1expasy.org

7,021^st place

low place

1pnas.org

1,293^rd place

619^th place

1ukpmc.ac.uk

low place

1archive.org

6^th place

14^th place

1nejm.org

2,374^th place

1,555^th place

archive.org

Hsia CC, Chin-Yee IH, McAlister VC (2008. July). „Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials”. Ann. Surg. 248 (1), 61–8. o. DOI:10.1097/SLA.0b013e318176c4ec. PMID 18580208.

doi.org

dx.doi.org

Roberts H, Monroe D, White G (2004). „The use of recombinant factor VIIa in the treatment of bleeding disorders”. Blood 104 (13), 3858–64. o. DOI:10.1182/blood-2004-06-2223. PMID 15328151.
Kenet G, Walden R, Eldad A, Martinowitz U (1999). „Treatment of traumatic bleeding with recombinant factor VIIa”. Lancet 354 (9193), 1879. o. DOI:10.1016/S0140-6736(99)05155-7. PMID 10584732.
O'Connell K, Wood J, Wise R, Lozier J, Braun M (2006). „Thromboembolic adverse events after use of recombinant human coagulation factor VIIa”. JAMA 295 (3), 293–8. o. DOI:10.1001/jama.295.3.293. PMID 16418464.
Hsia CC, Chin-Yee IH, McAlister VC (2008. July). „Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials”. Ann. Surg. 248 (1), 61–8. o. DOI:10.1097/SLA.0b013e318176c4ec. PMID 18580208.
Levi M, Levy JH, Andersen HF, Truloff D (2010. November). „Safety of recombinant activated factor VII in randomized clinical trials”. N. Engl. J. Med. 363 (19), 1791–800. o. DOI:10.1056/NEJMoa1006221. PMID 21047223.
Mayer S, Brun N, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick B, Steiner T (2005). „Recombinant activated factor VII for acute intracerebral hemorrhage”. N. Engl. J. Med. 352 (8), 777–85. o. DOI:10.1056/NEJMoa042991. PMID 15728810.
Mayer SA, Brun NC, Begtrup K, et al. (2008. May). „Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage”. N. Engl. J. Med. 358 (20), 2127–37. o. DOI:10.1056/NEJMoa0707534. PMID 18480205.
Carlsson, Karin, Freskgård Per-Ola, Persson Egon, Carlsson Uno, Svensson Magdalena (2003. Jun.). „Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor”. Eur. J. Biochem., Germany 270 (12), 2576–82. o. DOI:10.1046/j.1432-1033.2003.03625.x. ISSN 0014-2956. PMID 12787023.
Zhang, E, St Charles R, Tulinsky A (1999. Feb.). „Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant”. J. Mol. Biol., ENGLAND 285 (5), 2089–104. o. DOI:10.1006/jmbi.1998.2452. ISSN 0022-2836. PMID 9925787.

expasy.org

enzyme.expasy.org

Proconvertin - Enzyme Commission number: 3.4.21.21 (angol nyelven). [2012. szeptember 26-i dátummal az Enzyme Commission number: 3.4.21.21 eredetiből archiválva]. (Hozzáférés: 2012. július 23.)

nejm.org

Mayer SA, Brun NC, Begtrup K, et al. (2008. May). „Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage”. N. Engl. J. Med. 358 (20), 2127–37. o. DOI:10.1056/NEJMoa0707534. PMID 18480205.

nih.gov

pubmed.ncbi.nlm.nih.gov

Roberts H, Monroe D, White G (2004). „The use of recombinant factor VIIa in the treatment of bleeding disorders”. Blood 104 (13), 3858–64. o. DOI:10.1182/blood-2004-06-2223. PMID 15328151.
Kenet G, Walden R, Eldad A, Martinowitz U (1999). „Treatment of traumatic bleeding with recombinant factor VIIa”. Lancet 354 (9193), 1879. o. DOI:10.1016/S0140-6736(99)05155-7. PMID 10584732.
O'Connell K, Wood J, Wise R, Lozier J, Braun M (2006). „Thromboembolic adverse events after use of recombinant human coagulation factor VIIa”. JAMA 295 (3), 293–8. o. DOI:10.1001/jama.295.3.293. PMID 16418464.
Hsia CC, Chin-Yee IH, McAlister VC (2008. July). „Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials”. Ann. Surg. 248 (1), 61–8. o. DOI:10.1097/SLA.0b013e318176c4ec. PMID 18580208.
Levi M, Levy JH, Andersen HF, Truloff D (2010. November). „Safety of recombinant activated factor VII in randomized clinical trials”. N. Engl. J. Med. 363 (19), 1791–800. o. DOI:10.1056/NEJMoa1006221. PMID 21047223.
Mayer S, Brun N, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick B, Steiner T (2005). „Recombinant activated factor VII for acute intracerebral hemorrhage”. N. Engl. J. Med. 352 (8), 777–85. o. DOI:10.1056/NEJMoa042991. PMID 15728810.
Mayer SA, Brun NC, Begtrup K, et al. (2008. May). „Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage”. N. Engl. J. Med. 358 (20), 2127–37. o. DOI:10.1056/NEJMoa0707534. PMID 18480205.
Carlsson, Karin, Freskgård Per-Ola, Persson Egon, Carlsson Uno, Svensson Magdalena (2003. Jun.). „Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor”. Eur. J. Biochem., Germany 270 (12), 2576–82. o. DOI:10.1046/j.1432-1033.2003.03625.x. ISSN 0014-2956. PMID 12787023.
Zhang, E, St Charles R, Tulinsky A (1999. Feb.). „Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant”. J. Mol. Biol., ENGLAND 285 (5), 2089–104. o. DOI:10.1006/jmbi.1998.2452. ISSN 0022-2836. PMID 9925787.

pnas.org

Szöveti factor- Tissue factor (angol nyelven)

ukpmc.ac.uk

Szöveti Faktor-gátló (angol nyelven)^{[halott link]}

web.archive.org

Proconvertin - Enzyme Commission number: 3.4.21.21 (angol nyelven). [2012. szeptember 26-i dátummal az Enzyme Commission number: 3.4.21.21 eredetiből archiválva]. (Hozzáférés: 2012. július 23.)
Szöveti Faktor-gátló (angol nyelven)^{[halott link]}

worldcat.org

Carlsson, Karin, Freskgård Per-Ola, Persson Egon, Carlsson Uno, Svensson Magdalena (2003. Jun.). „Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor”. Eur. J. Biochem., Germany 270 (12), 2576–82. o. DOI:10.1046/j.1432-1033.2003.03625.x. ISSN 0014-2956. PMID 12787023.
Zhang, E, St Charles R, Tulinsky A (1999. Feb.). „Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant”. J. Mol. Biol., ENGLAND 285 (5), 2089–104. o. DOI:10.1006/jmbi.1998.2452. ISSN 0022-2836. PMID 9925787.